IBD Neoplasia Surveillance Pilot RCT

NACompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

November 6, 2020

Primary Completion Date

September 20, 2022

Study Completion Date

October 6, 2022

Conditions
Inflammatory Bowel DiseasesColonic NeoplasmsDysplasia
Interventions
DIAGNOSTIC_TEST

Intervention Group

Standard colonoscopy with targeted biopsies only

DIAGNOSTIC_TEST

Control Group

Standard colonoscopy with random AND targeted biopsies

Trial Locations (12)

Unknown

University of Alberta, Edmonton

St. Paul's Hospital, Vancouver

Pacific Digestive Health / Royal Jubilee Hospital, Victoria

University of Manitoba, Health Sciences Centre, Winnipeg

Nova Scotia Health Authority, Halifax

London Health Sciences Centre, University Hospital, London

Thunder Bay Regional Health Sciences Centre, Thunder Bay

Mount Sinai Hospital, Toronto

McGill University Health Centre, Montreal

A1B 3V6

Eastern Regional Health Authority, St. John's

L8L 8E7

Hamilton Health Sciences Corporation, Hamilton

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

Sponsors
All Listed Sponsors
collaborator

Health Sciences Centre, Winnipeg, Manitoba

OTHER

collaborator

Western University, Canada

OTHER

collaborator

University of Toronto

OTHER

collaborator

Hamilton Health Sciences Corporation

OTHER

collaborator

Thunder Bay Regional Health Sciences Centre

OTHER

collaborator

Eastern Health

OTHER

collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

collaborator

Providence Health & Services

OTHER

collaborator

Royal Jubilee Hospital

UNKNOWN

collaborator

University of Alberta

OTHER

collaborator

MOUNT SINAI HOSPITAL

OTHER

collaborator

Nova Scotia Health Authority

OTHER

lead

Ottawa Hospital Research Institute

OTHER